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ttp://dx.doi.org/10.1016/j.ajpath.2014.02.012Abnormalities in phosphoinositide metabolism are an emerging theme in human neurodegenerative
disease. Myotubular myopathy is a prototypical disorder of phosphoinositide dysregulation that is
characterized by profound muscle pathology and weakness and that is caused by mutations in MTM1,
which encodes a phosphatase that targets 3-position phosphoinositides, including phosphatidylinositol
3-phosphate. Although the association between MTM1 and muscle disease has become increasingly
clariﬁed, the normal role(s) of phosphatidylinositol 3-phosphate metabolism in muscle development
and homeostasis remain poorly understood. To begin to address the function of phosphatidylinositol 3-
phosphate in skeletal muscle, we focused on the primary kinase responsible for its production, and
created a muscle-speciﬁc conditional knockout of the class III phosphatidylinositol 3-kinase, Pik3c3.
Muscle-speciﬁc deletion of Pik3c3 did not disturb embryogenesis or early postnatal development, but
resulted in progressive disease characterized by reduced activity and death by 2 months of age. His-
topathological analysis demonstrated changes consistent with a murine muscular dystrophy. Exami-
nation for cellular mechanism(s) responsible for the dystrophic phenotype revealed signiﬁcant
alterations in the autophagolysosomal pathway with mislocation of known dystrophy proteins to the
lysosomal compartment. In all, we present the ﬁrst analysis of Pik3c3 in skeletal muscle, and report a novel
association between deletion of Pik3c3 and muscular dystrophy. (Am J Pathol 2014, 184: 1819e1830;
http://dx.doi.org/10.1016/j.ajpath.2014.02.012)Supported by NIH grants 1K08AR054835 (J.J.D.), HL080388 (D.E.M.),
and OD016502 (D.E.M.) and the Muscular Dystrophy Association (J.J.D.
and D.E.M.).
Disclosures: None declared.Phosphatidylinositols (PIs) comprise a group of low-
abundance lipids with hydroxylated inositol head groups
that are capable of receiving phosphates at any of the three
outer positions. Dynamic phosphorylation of the inositol ring
inﬂuences many cellular and metabolic processes, including
endocytosis, endosomal trafﬁcking, and autophagy.1e5 The
quantity and localization of different PIs are regulated by a
group of phosphoinositide kinases and phosphatases that
function as key regulatory enzymes and that have been
implicated in a number of human diseases, including espe-
cially oncologic and neurodegenerative diseases.6e9
Myotubular myopathy (MTM) is a severe childhood-onset
disease of skeletal muscle caused by mutations in the phos-
phoinositide phosphatase myotubularin gene (MTM1).10
MTM is characterized by profound weakness and hypoto-
nia at birth, persistent life-long disabilities including wheel-
chair and ventilator dependence, and early mortality.11 Asstigative Pathology.
.predicted by the fact that MTM1 has been shown in vitro to
be responsible for dephosphorylation of PI(3)P, levels of
PI(3)P are signiﬁcantly elevated in animal models of
MTM.12e14 Despite growing knowledge of disease patho-
genesis, there are currently no available treatments for MTM.
One signiﬁcant barrier toward therapy development for
MTM is the fact that the normal function(s) of PI(3)P in
skeletal muscle are unknown.
PI(3)P is created through phosphorylation of PI at the D3
position by PI3 kinases,15,16 or through dephosphorylation of
PI(3,5)P2 by the phosphatase FIG4.
17 There are three classes
of PI3 kinases that produce PI(3)P in mammals, with varying
Reiﬂer et altissue expression and substrate speciﬁcity.18,19 In skeletal
muscle, the primary sources of PI(3)P are hypothesized
(based on gene expression) to be the class III kinase, Pik3c3
(hVPS34), and the class II kinase Pik3c2b, with PIK3C3
considered the major enzymatic regulator of its produc-
tion.15,16,20 Previous studies of PIK3C3 have identiﬁed it as a
regulator of several intracellular processes, including endosome-
to-Golgi membrane trafﬁc,7 endocytosis,21,22 mTOR-S6K1
signaling,23,24 and autophagy. Perhaps its best-studied func-
tion is in autophagy, where PIK3C3 and its regulatory subunit
PIK3R4 (Vps15) form multiple complexes with other auto-
phagy gene products to regulate several steps of autophagosome
formation and maturation.25e28
The goal of the present study was to begin understanding
the role of PI(3)P in skeletal muscle by evaluating the
function of PIK3C3. As previously reported, whole-animal
gene knockout of Pik3c3 in the mouse results in early
embryonic lethality.29,30 Therefore, to study PIK3C3 spe-
ciﬁcally in muscle, we have used the Cre-lox system. Cre-
loxemediated knockout of Pik3c3 has been performed in
kidney,31 liver, and heart32; sensory, cortical, and hippo-
campal neurons30,33; and T cells,34 but Pik3c3 has yet to be
examined in skeletal muscle. We generated mice with
conditional knockout of Pik3c3 in skeletal muscle by
combining ﬂoxed Pik3c330 and Cre recombinase under the
muscle creatine kinase promoter: Tg(Ckmm-Cre).35 The
resulting mice had normal embryonic and early postnatal
development, but died by 2 months of age, presumably from
severe cardiomyopathy.32 Somewhat surprisingly, exami-
nation of skeletal muscle in knockout animals revealed a
murine muscular dystrophy. We present the comprehensive
characterization of this dystrophic phenotype. In total, we
report for the ﬁrst time a requirement for Pik3c3 in skeletal
muscle homeostasis, and further identify loss of Pik3c3 as a
cause of muscular dystrophy in the mouse.
Materials and Methods
Care and Treatment of Animals
All care and treatment of animals was implemented through
protocols carefully monitored by the University Committee
on Use and Care of Animals. The University of Michigan’s
Unit for Laboratory Animal Medicine carefully monitored
the health of the rodent colonies. The Unit for Laboratory
Animal Medicine maintained proper environmental regula-
tion, including temperature and light cycles, unlimited access
to water, appropriate food supply, and clean enclosures. Pups
were weaned from their mothers according to standard pro-
tocols, and tails were clipped for genotyping, as described.
Generation of Mutant Mouse Strains
Floxed Pik3c3 mice, a kind gift from Dr. Fan Wang (Duke
University, Trinity, NC), were described in Zhou et al.30 Cre
mice are of the strain: B6.FVB(129S4)-Tg(Ckmm-cre)18205Khn/J, obtained from the Jackson Laboratory (Bar Har-
bor, ME). Mice were crossed to make Pik3c3ﬂ/þ;Creþ
heterozygous mice, and in-crossed to produce the double-
ﬂoxed allele Pik3c3ﬂ/ﬂ, resulting in the muscle-speciﬁc
conditional knockout animals.
Genotyping of Mutant Mouse Strains
Protocols and primers for genotyping mice were described
previously.30
Quantitative PCR
Total mRNA was isolated from muscle homogenates using
QIAGEN RNeasy kits (Qiagen, Valencia, CA), and quanti-
tative PCR (qPCR) was performed using cDNA reverse-
transcribed by iScript (BioRad Laboratories, Hercules, CA)
on ABI equipment (Applied Biosystems; Life Technologies,
Carlsbad, CA) using SYBR Green reagents (Life Technolo-
gies). Analysis was done by using the DDCt method. Primers
for transcripts analyzed were previously described.36
Western Blot Analysis
Protein was isolated from tissue from KO and littermate
mice by mincing and homogenizing in T-PER buffer
(Thermo Fisher Scientiﬁc, Waltham, MA) with proteinase
inhibitors (Roche, Basel, Switzerland), with brief sonication
on ice. Loading buffer was added to protein and run on 10%
to 15% acrylamide gels, followed by transfer to poly-
vinylidene diﬂuoride blots. Primary antibodies were applied
overnight at 4C at 1:1000 dilution in 3% bovine serum
albumin, 0.5% Triton X-100, NaF.
Indirect analysis of protein expression was performed
using standard methodology and the ImageJ program
version 1.45k (NIH, Bethesda, MD).
Histology
Animals were sacriﬁced by anesthetic injection followed by
cervical dislocation, and tissues were isolated using sterile
surgical methods without the use of laminar ﬂow hoods.
Muscle tissue from quadriceps and tibialis anterior was
dissected and mounted onto small balsawood pieces that
were previously frozen with drops of optimal cutting tem-
perature compound (Tissue-Tek; Thermo Fisher Scientiﬁc),
and then semithawed with light friction. The mounted
muscle tissue was immediately submerged in a 55C
isopentane bath cooled by liquid nitrogen for ﬂash freezing.
Muscles were cut in 12-mm cross sections and mounted on
Superfrost Plus slides (Thermo Fisher Scientiﬁc) using a Leica
cryostat (Leica Microsystems, Wetzlar, Germany) at 20C,
and dried at room temperature before storage at 80C.
Micrographs were captured with an Inﬁnity1 camera
(Lumenera Corporation, Ottawa, ON, Canada) with epony-
mous software visualized through an Olympus BX43 lightajp.amjpathol.org - The American Journal of Pathology
Pik3c3 Knockout and Muscular Dystrophymicroscope (Olympus, Tokyo, Japan). Images were cropped
in Adobe Photoshop and arranged for ﬁgures with Adobe
Illustrator (both programs from Creative Suite 6; Adobe
Systems, San Jose, CA).
Standard techniques for indirect ﬂuorescent immunohis-
tology were used. Snap-frozen tissues were cryosectioned
and collected on Superfrost slides. After allowing sections
to dry, they were washed with PBS to remove residual OCT.
Slides were blocked for more than 30 minutes at room
temperature in a solution of 0.25 mol/L KCl, 0.20 mmol/L
HEPES with 1% bovine serum albumin, 0.1% gelatin,
0.02% NaN3, and 0.1% Triton X-100 (pH 7.9). Slides were
incubated overnight at 4C with Progen guinea pig anti-p62
antibody (PROGEN Biotechnik, Heidelberg, Germany),
diluted 1:100 in blocking solution. After three washes in
PBS, secondary antibodies (Alexa Fluor 488 conjugated
with goat anti-guinea pig IgG; Life Technologies) were
applied for 1 hour at room temperature, diluted 1:1000 in
blocking solution. Slides were washed several times to
remove excess secondary antibody and then mounted with
ProLong Gold (Life Technologies).
Bright-Field Imaging and Fiber Size Analysis
Slides were stained with Mayer’s H&E following standard
protocols, and then mounted with Permount (Thermo Fisher
Scientiﬁc).
Postcapture analysis, including tests of statistical signiﬁ-
cance, was performed using Microsoft Excel 2008 (Micro-
soft, Redmond, WA) and GraphPad Prism version 5 for
MacOSX (GraphPad Software, La Jolla, CA).
Transmission Electron Microscopy
Immediately following dissection, tips of quadriceps were
carefully cut into approximately 1  2-mm fragments, and
incubated in Karnovsky’s ﬁxative overnight at 4C.
The ﬁxed tissue was brought to the Microscopy and
Image Analysis Laboratory (MIL) core facility at the Uni-
versity of Michigan for processing. Ultrathin sections were
analyzed for orientation, and grids were prepared for use on
the Phillips CM-100 transmission electron microscope
(Philips, Eindhoven, the Netherlands).
Measurements of Serum Creatine Phosphokinase
Serum was collected from the saphenous vein of restrained
animals and stored at 80C. Creatine kinase activity was
measured in duplicate using CK NADP Reagent (Cliniqa,
San Marcos, CA).
Evans Blue Dye Uptake Assay
Evans Blue dye (EBD) was injected i.p. and allowed to
inﬁltrate tissues over the course of 24 hours before mice
were sacriﬁced and tissues sectioned as described above.The American Journal of Pathology - ajp.amjpathol.orgEchocardiographic Analysis
Echocardiograms were taken of the mice as described
previously.21
PI(3)P Enzyme-Linked Immunosorbent Assay
Lipid analysis was performed by indirect analysis of whole-
muscle lysates using Echelon’s PI(3)P Mass ELISA kit
(K-3300) (Echelon Biosciences, Salt Lake City, UT), as
previously described.14
Results
Generation and Veriﬁcation of Muscle-Speciﬁc Pik3c3
Knockout Mice
We generated muscle-speciﬁc Pik3c3 knockout mice by
breeding mice harboring a conditional null mutant allele, in
which exons 17 and 18 of Pik3c3 are ﬂanked by LoxP sites
(Pik3c3ﬂ/þ),30 with previously characterized transgenic mice
expressing Cre recombinase under the muscle creatine ki-
nase (Ckmm) promoter Tg(Ckmm-Cre).35 Heterozygous
animals (Pik3c3ﬂ/þ;TgCkmm-Creþ) were intercrossed to
produce Pik3c3 muscle-speciﬁc knockout mice (TgCkmm-
Creþ;Pik3c3ﬂ/ﬂ), referred to as Pik3c3-KO, or simply KO,
and sibling mice, referred to as littermate controls or wild
type (WT). An example of PCR-based genotyping, using
previously published primers,30 from a representative cross
is presented in Figure 1A.
To verify that we successfully achieved knockdown of
Pik3c3 expression, we compared both transcript and protein
levels from skeletal muscle of knockout mice and age-
matched littermates. qPCR revealed an average reduction
in skeletal muscle of (mRNA) Pik3c3 levels of 82  31%
(SEM) in knockout mice compared to WT (n Z 4,
P Z 0.038) (Figure 1C). Western blot analysis of extracts
from quadriceps muscle demonstrated an average reduction
of PIK3C3 protein levels to 11  4% (SEM) of WT (nZ 3,
P < 0.001) (Figure 1, B and D). Lastly, we examined
PIK3C3 expression in muscle by immunostaining. In WT
quadriceps, we observed a patchy pattern of expression that
was both along the plasma membrane and within the
sarcoplasm (Figure 1F). This expression was qualitatively
and uniformly diminished in the muscle from knockout
animals (Figure 1G). Faint expression can be appreciated,
and in one sample, we observed a very small number of
more brightly staining ﬁbers. These data may indicate that
the 11% remaining PIK3C3 observed on Western blot
analysis could be from residual protein within the myoﬁber.
Alternatively (or in addition), it may be from other cell types
such as ﬁbroblasts and blood vessels.
PIK3C3 is hypothesized to be the primary kinase that
generates PI(3)P. To determine the consequence of reduced
PIK3C3 levels on PI(3)P levels, we next examined PI(3)P
levels from quadriceps muscle of knockout animals and1821
Figure 1 Muscle-speciﬁc Pik3c3 knockout causes a signiﬁcant decrease
in PIK3C3 and PI(3)P levels. Muscle-speciﬁc knockout of Pik3c3 was
conﬁrmed through direct (DNA, mRNA, protein) and indirect [PI(3)P level]
measures. Samples were obtained from quadriceps muscle tissue isolated
from 6- to 8-week-old mice, with age-matched littermate controls, unless
otherwise noted.A:Genotypingofmice harboringhomozygousﬂoxed (ﬂ/ﬂ ),
heterozygous (ﬂ/þ), or WT (þ/þ) alleles. B: As measured by qPCR, a sig-
niﬁcant decrease in Pik3c3 transcript levels (17.7  4.7%, n Z 4) was
detected in skeletal muscle from knockout (KO) animals. C: Values were
normalized to Gapdh transcript levels, with WT average value set at 100%
(31%,nZ 4).Western blot analysis conﬁrmed reduction of PIK3C3 levels in
skeletal muscle from KO animals. D: Quantitation of PIK3C3 protein levels as
determined by densitometric analysis, using b-actin protein levels as a
loading control, showed a decrease from WT levels (100  5.4%) to
11.0  1.0%. E: PI(3)P levels are reduced in KO animals, as determined by
using a PI(3)P ELISA kit [puriﬁed lipid (pmol)/mass (g) ofmuscle tissue] (WT:
3967 225, nZ 9; KO: 1982 334, nZ 8). Error bars are presented as SEM.
Immunostaining with anti-Pik3c3 antibody of sections of quadriceps fromWT
littermate (F) and KO (G). Staining inWTwas along the plasmamembrane and
in puncta in the sarcoplasm. Staining in KO animals was dramatically reduced,
but sarcoplasmic puncta can still be appreciated. Data are expressed asmeans
 SEM. *P < 0.05, ***P < 0.001. Scale bars: 20 mm (F and G).
Reiﬂer et alwild type littermates. We did this using an established PI(3)
P enzyme-linked immunosorbent assay (ELISA).14 ELISA-
based analysis revealed a reduction of PI(3)P levels in
skeletal muscle of knockout animals to 50% of controls
(n Z 9) (Figure 1E). This level of reduction is consistent,
though somewhat less than the reduction of the amount of
PIK3C3 protein, and supports the previous assumption that
PIK3C3 is a primary (but not sole) kinase responsible for
PI(3)P production in skeletal muscle. Of note, we cannot
exclude that some or even most of the remaining PI(3)P is1822due either to residual PIK3C3 expression in myoﬁbers or
else to PIK3C3 expression in the nonmuscle cell types that
are present in total muscle extracts.
Muscle-Speciﬁc Knockdown of Pik3c3 Results in
Premature Lethality
KO animals appeared normal at birth, and are qualitatively
similar to littermates through the ﬁrst month of extra-uterine
life (Figure 2, A and B). This was revealed subjectively
through animal appearance and activity, and objectively by
analysis of body weight of sex-matched animals, because
comparisons did not show signiﬁcant differences (Figure 2,
AeC). In addition, skeletal muscle tissue taken from ani-
mals sacriﬁced within the ﬁrst month appeared histologi-
cally normal (Supplemental Figure S1).
However, between 40 and 60days of age,KOanimals began
to exhibit an overt phenotype consisting mainly of reduced
voluntary activity (Supplemental Video S1) and an abnormal
suspension test (SupplementalVideo S2). The youngest animal
observed in our cohort to demonstrate overt phenotypic
changes did so at age 42 days (nZ 27, KO animals). Shortly
after ﬁrst signs of disease, the KO animals displayed progres-
sively reducedmobility aswell as earlymortality. Theyoungest
age of death was at 42 days of age, whereas the oldest living
knockout animal survived only to 62 days (Figure 2D). The
exact cause of death in KO animals was not precisely known,
though we strongly suspect it is related to cardiac disease.
Pik3c3 Knockout Causes a Severe Dilated
Cardiomyopathy
Because the Ckmm promoter expresses in cardiac and
skeletal muscle, we next examined the hearts of KO ani-
mals. We ﬁrst analyzed levels of Pik3c3 transcript from
heart tissue by qPCR (Figure 3A), and showed an average
reduction of 87  3%. We next examined the gross
anatomical phenotype of the hearts, and observed a dramatic
increase in heart size, with the average knockout heart-to-
body-mass ratio measuring 250% of age-matched controls
(Figure 3, B and C). Low-magniﬁcation histopathological
analysis corroborated this anatomical observation, revealing
qualitative enlargement and thickening of both atrium and
ventricle (n Z 3) (Figure 3D). In addition, echocardiogra-
phy showed evidence of signiﬁcant cardiac hypertrophy and
severe cardiac dysfunction (Figure 3E and Supplemental
Table S1). Although the B-mode measurements of cham-
ber dimensions were largely unchanged, all measurements
of septal and posterior left ventricular wall thickness by M-
mode were signiﬁcantly increased in KO mice (Figure 3E),
with an estimated ventricular mass consistent with the
morphological ﬁndings in isolated hearts. Indices of systolic
function, including ejection fraction and stroke volume, and
cardiac output were all decreased in KO, whereas the resting
heart rate was unchanged (Supplemental Table S1). Dia-
stolic function was also impaired as indicated by an increaseajp.amjpathol.org - The American Journal of Pathology
Figure 2 Muscle-speciﬁc Pik3c3-cKO animals have a reduced life span. The
disease phenotype of knockout (KO) mice develops after 1 month, and affected
mice die rapidly after onset of symptoms. A: Despite abnormal levels of activity,
KO mice are difﬁcult to distinguish by overall appearance from WT littermates,
even at 6 weeks of age (KO mouse is on the left). B: There is no signiﬁcant
difference in the body mass of KO animals (slope, P Z 0.21) than that of WT,
though weights tend to be smaller than age-matched WT littermates toward the
end of KO disease progression (lines represent linear regression; WT, n Z 3; KO
n Z 4). C: Terminal body mass of WT (22.7  0.57 g for males and 17.7  0.24
g for females) and KO animals (21.4  0.38 g for males and 17.4  0.29 g for
females) are not signiﬁcantly different (unpaired t-tests for males, P Z 0.075,
nZ 9; for females, PZ 0.45, nZ 5). D: KO mice die between 6 and 8 weeks of
age, with median survival of 54 days (KO, n Z 11, with an equal number of WT
littermates were sacriﬁced to match age and sex of KO mice). Data are expressed
as means  SEM (C).
Pik3c3 Knockout and Muscular Dystrophyin isovolumic relaxation time and ratio of mitral valve E
blood velocity to E0 tissue Doppler velocity at the septal
annulus. In all, our analysis supports the conclusion that
Pik3c3 deletion in the heart causes a severe cardiomyopathy.
Of note, our results are consistent with a previously published
study using cre-lox knockout of Pik3c3.32The American Journal of Pathology - ajp.amjpathol.orgPik3c3 Knockout Results in a Murine Muscular
Dystrophy
Because our primary interest in creating conditional knockouts
of Pik3c3 was to examine its requirement for skeletal muscle
development and homeostasis, we focused all subsequentFigure 3 KO animals display cardiac abnor-
malities. A: As measured by qPCR, Ckmm-driven cre
expression in the heart leads to 87% reduction in
levels of Pik3c3 transcript in KO (13.4  1.2%) as
compared to WT controls (100  2.9%). B: Obvious
cardiomegaly is observed in KO animals . C: Hearts
in KO animals are two to three times the size of
WT littermates. Increases in heart mass to body
mass ratios are consistent in affected males
(254  16.1%) and females (234  16.9%). D:
Cross-sectional histology of hearts with Sirius Red
stain demonstrates increased thickness of walls
with no observable ﬁbrosis (aged 45 days). E:
Representative M-mode echocardiograms from the
left ventricle of KO mice show marked left ven-
tricular wall hypertrophy compared to age-
matched WT littermate mice. Data are expressed
as means  SEM. nZ 2 (A and C). ***P < 0.001.
Scale bar Z 50 mm (B).
1823
Figure 4 KO animals have aberrant histology. Histological analysis of
KO skeletal muscle shows signs of muscular dystrophy. Sections were taken
from gastrocnemius muscle of 60-day-old WT and KO animals, and stained
with H&E. A and B: Low-magniﬁcation (20) images reveal inﬂammatory
inﬁltrate (arrows) and changes consistent with degeneration and regen-
eration (arrowheads). CeF: Higher magniﬁcation (40) micrographs
show changes as in (A) and (B) but also better reveal abundant internal
nuclei.
Reiﬂer et alstudies on skeletal muscle. We began our analysis by per-
forming routine histopathology studies from quadriceps,
gastrocnemius, and tibialis anterior muscles. H&E staining of
fresh-frozen, cryosectioned muscle from 42- to 60-day-old
animals revealed clearly abnormal areas with features that
included inﬂammatory inﬁltrates (small blue cells), and
degenerating and regenerating ﬁbers (Figure 4). Within these
areas of abnormal muscle, there was a signiﬁcant increase in
myoﬁberswith internalized nuclei (Supplemental Figure S2A),
consistent with muscle regeneration (Figure 4, A and B). In
total, the histopathological changes (inﬂammatory cells,
increased internal nuclei, and degenerating ﬁbers) were
consistent with a murine muscular dystrophy. These changes
were seen in all muscle groups evaluated and in multiple
different animals (nZ 5).1824Of note, there were as well areas of relatively unaffected
muscle next to areas with dystrophic changes. In addition,
muscles harvested from older knockout animals had more
areas of aberrant ﬁbers, whereas (as mentioned above)
muscle analyzed before 1 month of age appeared normal
(Supplemental Figure S1). Also, the average ﬁber size was
not signiﬁcantly different between knockouts and their lit-
termates (Supplemental Figure S2B). Lastly, we did not
observe an increase in ﬁbrosis in dystrophic muscle areas of
the knockout animals (Supplemental Figure S3).
To corroborate the histopathological observation of
dystrophic muscle in Pik3c3 knockout mice, we used two
additional strategies (Figure 5). The ﬁrst was to measure
serum creatine phosphokinase (CPK) levels. We obtained
blood samples from the saphenous vein of animals that were
not previously exposed to strenuous exercise or diet modi-
ﬁcations. CPK levels were signiﬁcantly and highly elevated
(P Z 0.0062). The average level in 45-day-old mice was
almost 20-fold higher in conditional knockout animals
(5450  1260, n Z 4) as compared to their littermate
controls (230  66, n Z 4) (Figure 5A).
The second measure of muscular dystrophy was assess-
ment of EBD uptake in skeletal muscle (Figure 5B). After
systemic injection of EBD, damaged/dystrophic ﬁbers
demonstrate dye uptake, whereas healthy ﬁbers do not. As
compared to wild types, there was a visible increase in EBD-
positive ﬁbers, indicating damaged muscle in the knockouts.
Importantly, there was only a slight increase in EBD in the
hearts of knockout animals (Supplemental Figure S4, AeD),
suggesting that the elevated CPK levels found in the
knockouts are most likely from skeletal (and not cardiac)
muscle breakdown. In all, based on histopathology, serum
CPK levels, and EBD studies, we concluded that reduction of
Pik3c3 expression resulted in a murine muscular dystrophy.
Onset of Muscular Dystrophy Correlates with Relative
Pik3c3 Expression
To better understand the timing of disease in the Pik3c3-
cKO animals, we examined relative RNA expression during
muscle development using RT-qPCR. We detected rela-
tively little expression in newborn and 1-month-old muscle,
and increasing levels of RNA at both 2 and 3 months
(Supplemental Figure S5A). This increase in expression
correlates with the timing of dystrophic changes. Another
consideration related to both the timing and severity of
dystrophy is potential compensation by the class II PI3
kinases. We thus examined expression of Pik3c2a, Pik3c2b,
and Pik3c2g in skeletal muscle during muscle development
from WT and knockout mice. This analysis revealed two
observations. The ﬁrst is that Pik3c2b, but not Pik3c2a or
Pik3c2g, is abundantly expressed in 2- and 3-month-old
WT muscle. The second is that there was no statistical
change in RNA levels of any class II kinase in knockout
samples as compared to WT littermates (Supplemental
Figure S5B).ajp.amjpathol.org - The American Journal of Pathology
Figure 5 Pik3c3-cKO mice exhibit dystrophic
muscle by independent measures. A: CPK measure-
ments of serum obtained from the distal saphenous
vein show increases of nearly 50-fold in excess when
KO (meanZ 5452 1263 mU/mL) are compared to
WT littermates (meanZ 233.3 65.51 mU/mL). B:
EBD is taken up by dystrophicﬁbers after 24 hours of
incubation following peritoneal injection. EBD is
shown in red and counterstained against the
extracellular membrane protein Laminin in green.
Data are expressed as means SEM. nZ 4 KO and 4
WT mice. ***P < 0.001.
Pik3c3 Knockout and Muscular DystrophyUltrastructural Analysis Reveals Aberrant Membrane
Structures
We performed analysis of skeletal muscle ultrastructure to
look for clues related to muscle disease pathogenesis.
Despite elevated CPK levels and abnormal EBD update, no
obvious membrane discontinuities or tears were observed in
KO muscle. However, there were widespread and striking
abnormalities in several subcellular structures (Figure 6).
Speciﬁcally, among the various abnormalities we observed,
we detected frequent swellings associated with internal
sarcolemmal membranes, as well as aberrantly appearing
mitochondria (Figure 6B). We also observed degradation
compartments surrounded by double membranes, a ﬁnding
consistent with aberrant autophagy (Figure 6, C and E).
Overall, these changes were consistent with a defect in
membrane turnover,37 and resemble changes seen in skeletal
muscle with defective autophagy.38The American Journal of Pathology - ajp.amjpathol.orgAutophagy Genes Have Aberrant Expression and
Localization in KO Animals
One of the functions of PIK3C3 in vitro is regulation of
the initiation of autophagy. Given that the ultrastructural
changes were reminiscent of defective autophagy, we exam-
ined KO muscle for evidence of aberrant autophagy. We
examined autophagy using three approaches: i) measurement
of autophagy-related gene expression changes by qPCR; ii)
examination of autophagic markers byWestern blot analysis;
and iii) study of markers by immunocytochemistry. qPCR
revealed signiﬁcant increases in transcripts associated with
autophagy, including up-regulation of p62 (4.5  0.97 fold
change) and LC3 (3.3  0.53 fold change) (Figure 7A). We
also detected increased expression of gene products associ-
ated with muscle atrophy, such as ubiquitin ligases atrogin-1
(7.0 1.7 fold change) andMuRF1 (3.1 0.71 fold change).
Similarly, we observed signiﬁcant increases in levels of theFigure 6 Ultrastructural analyses by trans-
mission electron microscopy show aberrant fea-
tures in KO mice. Tissue from tibialis anterior
muscle of 6-week-old mice was analyzed by elec-
tron microscopy. Evaluation of transmission elec-
tron micrographs of WT littermate controls (A) and
KO (BeE) reveals numerous defects in muscle ul-
trastructure, including sarcoplasmic swellings in
addition to aberrant vacuoles (arrows) and mito-
chondria (arrowheads). Scale bars: 2 mm (A and
B); 1 mm (E).
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Figure 7 KO mice exhibit aberrant markers of basal autophagy. Transcript levels were measured from mRNA isolated from quadriceps of 2-month-old KO
and WT littermates. A: Results using primers for Map1-Lc3 (3.3  0.53 fold change), p62 (4.5  0.97 fold change), Murf1 (3.1  0.71 fold change), Atrogin1
(7.0  1.7 fold change), CathepsinL (9.1  1.8 fold change), Bnip3 (0.92  0.2 fold change), and Bnip3l (0.86  0.23 fold change) were normalized to Gapdh
internal controls. The y axis indicates fold increase normalized to littermate controls for DDCt (nZ 3). B and C: Protein was isolated from quadriceps of 2-
month-old KO and WT littermates for analysis by Western blot with antibodies against MAP1-LC3 and p62. D: Densitometric analysis of LC3-I/II, performed
using GAPDH as an internal control (nZ 2), shows increases in LC3-I (604  137%, *P < 0.05) and LC3-II (420  118%), and a ratio of LC3-I:LC3-II that is
slightly increased (147  12%). E: Densiometric analysis of blot probed with p62 antibody shows increase in KO muscle to 1593  137% that of WT controls,
using b-actin as internal control (nZ 3). FeH: Sectioned gastrocnemius muscle from 60-day-old animals stained using immunochemistry shows accumulation
of p62/SQSTM1. Data are expressed as means  SEM. *P < 0.05, **P < 0.01, and ***P < 0.001.
Reiﬂer et allysosomal proteinase, cathepsin L (9.1  1.8 fold change).
Although other reports36 on muscle wasting have shown up-
regulation in Bnip3 and Bnip3l, levels of these transcripts
were unaffected by the Pik3c3 knockout: Bnip3 had a
0.92  0.2 fold change and Bnip3l gave a 0.86  0.23 fold
change when normalized to WT animals. This is consistent
with the fact that we did not detect any corresponding alter-
ations in overall muscle size or in the size of individual ﬁbers
(Supplemental Figure S2).
We next examined autophagy by looking at protein
markers of the pathway. Western blot analysis showed
signiﬁcant increases in total protein levels of LC3 and p62:1826LC3-I increased 604  137% and LC3-II by 420  118%,
with the ratio of LC3-I:LC3-II only slightly increased
(147  12%) (Figure 7, BeE); p62 antibody showed in-
creases in KO muscle to 1593  137% that of WT controls,
using b-actin as an internal control (n Z 3). These changes
are consistent with defective autophagic ﬂux and with the
measurements of transcript levels. We performed immuno-
cytochemical analysis using an antibody to p62, a protein
associated with the initiation of autophagy that accumulates
when autophagic ﬂux is impaired. We observed signiﬁcant
accumulation of p62 with ﬁbers of KO animals, as
compared to essentially absent staining in age-matchedajp.amjpathol.org - The American Journal of Pathology
Figure 8 Aberrant accumulation of membrane-associated proteins indicates trafﬁcking dysfunction. Sectioned gastrocnemius muscle from 60-day-old
animals stained using immunochemistry shows accumulation of LAMP1 (A and D), caveolin-3 (B and E), and dystrophin (C and F) in KO animals compared to
littermate controls. G: Western blot analysis of cathepsin D reveals alterations in the processing of the mature form in KO animals from procathepsin D (Pro),
preprocathepsin D (Pre), and cathepsin D heavy chain (HC) isoforms. H: Densiometric analysis reveals signiﬁcant decreases in the levels of Pre and HC isoforms,
demonstrated as overall levels normalized to b-actin and as total fraction of cathepsin D. **P < 0.01.
Pik3c3 Knockout and Muscular Dystrophycontrol siblings (Figure 7, FeH). In total, KO resulted in up-
regulation of markers of autophagy, but rather than showing
turnover of key proteins, we witnessed an accumulation of
the markers of autophagosome formation, consistent with an
overall impairment in the initiation of autophagy.
Loss of PIK3C3 Causes Impairment in Lysosomal
Function
Because aberrant autophagy alone is unlikely to explain the
histopathological changes we observed, we sought to un-
cover additional potential causes for dystrophic muscle pa-
thology in the KO mice. Because elevated CPK levels and
increased EBD uptake were suggestive of compromised
integrity of the muscle’s external membrane, we analyzedThe American Journal of Pathology - ajp.amjpathol.orgexpression and localization of integral membrane proteins
using immunohistochemistry. We observed striking changes
in the localization of both dystrophin and caveolin-3. In
numerous muscle ﬁbers from KO (but not WT) animals,
these proteins, although still present at the membrane, also
accumulated within the myoﬁber (Figure 8, B, C, E, and F).
The mislocalization of these proteins occurred without a
change in their overall levels, as determined by Western blot
analysis (Supplemental Figure S6).
Internal accumulation of membrane proteins has been pre-
viously reported in the setting of abnormal lysosomal func-
tion.28 We therefore sought to interrogate lysosomal function
in our knockout animals. We examined LAMP1 staining, and
found two important changes as compared to WT mice
(Figure 8, A and D): accumulation of LAMP1 staining within1827
Reiﬂer et almyoﬁbers as well as increased intensity of LAMP1 staining
around the plasma membrane. Both ﬁndings have been
observed in other models of lysosomal dysfunction.39 To
quantitate a possible abnormality in lysosomal function, we
looked at cathepsin-D processing by Western blot analysis.
Cathepsin-D processing is used as a marker for the normal
functioning of the lysosome. We found a signiﬁcant decrease
in the mature forms of cathepsin-D, suggesting a signiﬁcant
abnormality in the ability of the lysosome to cleave cathepsin
to its mature, active form (Figure 8, G and H). Taken together
with the immunostaining results for LAMP1, dystrophin, and
caveolin-3, these results are consistent with impaired lyso-
somal function and suggest aberrant lysosomal processing as
the cause of membrane protein mislocalization.Discussion
In summary, we have generated muscle-speciﬁc knockout
mice of Pik3c3 (Vps34) and provided the ﬁrst phenotypic
description of the role of PIK3C3 in skeletal muscle.
Knockout mice had reduced levels of Pik3c3 mRNA and
protein in striated muscle, and had signiﬁcantly reduced
levels of PI(3)P, the phospholipid generated by PIK3C3.
Using both morphological and functional analyses, we
identiﬁed signiﬁcant changes in skeletal and cardiac muscle
structure and function and in the overall health of the ani-
mals, including premature lethality in the second postnatal
month. Our results speciﬁcally identify PIK3C3 as a gene
product required for normal muscle structural integrity and
for the regulation of basal autophagy and lysosome function
in skeletal muscle.
One of the most signiﬁcant ﬁndings in our study was the
appearance of dystrophic muscle pathology in affected mice.
This observation was in contrast to our pre-experiment
prediction that loss of Pik3c3 would be associated with ab-
normalities similar to those observed with myotubularin
dysfunction, because both overexpression and knockout of
Mtm1 cause signiﬁcant disruption of the sarcotubular
network and (at least for Mtm1 knockout) a centronuclear
myopathy phenotype. KO mice clearly did not have a cen-
tronuclear myopathy, but instead had changes consistent with
a muscular dystrophy. The presence of a dystrophy was
established based on histopathology, CPK levels, and EBD
staining, and our study thus provides a connection between
dysfunction in PIP regulation and dystrophic muscle pa-
thology. Of note, a recent study described the muscle-speciﬁc
knockout of Vps15, which functions as a co-factor of
PIK3C3 and is required for many aspects of PIK3C3 func-
tion. These mice similarly manifested a murine muscular
dystrophy, a ﬁnding that corroborates the data from the
present paper.28
The appearance of dystrophic pathogenesis gives insight
into the involvement of PIK3C3 in pathways other than ca-
nonical Beclin-complexemediated autophagy. On the basis
of previous knockout mice studies, it is unlikely that the1828defects in autophagy we observed in KOs are sufﬁcient to
explain the severe muscular dystrophy seen in these animals.
Speciﬁcally, disruption of the essential components of auto-
phagic machinery Atg7 and Atg5 does not result in dystrophic
pathology, but instead a mild myopathy characterized by
reduced myoﬁber size.40,41 Instead, we postulate that abnor-
malities in lysosomal function are more likely to be the cause
of the dystrophic animals. This assertion is supported by two
major observations. The ﬁrst is that mutations in the lyso-
somal proteins LAMP2 and GAA both result in skeletal
muscle disease (Danon disease39 and Pompe disease,42
respectively) with dystrophic features. The second is that
lysosomal function (and in particular, lysosomal exocytosis)
has been implicated in the regulation of membrane repair,43
and defective membrane repair is a well-established trigger
for the development of muscular dystrophy.44 Additional
experimentation will obviously be necessary to speciﬁcally
establish why the loss of PIK3C3 function causes a muscular
dystrophy, and to parse out which of the many potential
functions of the protein are responsible for regulating mem-
brane integrity in skeletal muscle.
Of note, there are several independent studies of mice with
conditionally deleted alleles of Pik3c3, including neurons,30
in T cells,34 in podocytes,31 and in heart and liver.32
Consideration of these studies together reveals several
common features of organs lacking PIK3C3 that are seen as
well in our muscle-speciﬁc deletion. These include aberrant
autophagy, disrupted cellular homeostasis, and overall
degeneration of tissues. Also, there are some speciﬁc dif-
ferences when comparing studies of different cell types,
including controversy over which stages of autophagy are
most affected by loss of PIK3C3 function.28,32 It should be
noted that there are still many aspects of autophagy initiation
and regulation that are not well understood, such as the extent
of noncanonical pathways (sans Beclin-1), and cells use
multiple processes for sequestering and/or delivering targets
to the lysosome.45 Future studies of the various knockout
strains of PIK3C3 may help illuminate these issues.
Lastly, it should also be noted that PIK3C3 is likely not the
only means for generating PI(3)P in skeletal muscle. This
assertion is supported by the fact that we observe a 50%
reduction in PI(3)P levels in the muscle of knockouts, despite
achieving much higher levels of PIK3C3 reduction. Although
the residual expression of PIK3C3 (both in myoﬁbers and
perhaps in nonmuscle cell types) in our knockout animals
likely accounts for some of the PI(3)P production, we specu-
late that other PI3 kinases may also participate in its synthesis.
One candidate for generating a fraction of PI(3)P in skeletal
muscle is PIK3C2B, a class II PI-3 kinase that is expressed in
skeletal muscle and whose function is poorly understood. We
conﬁrm in this study that Pik3c2b transcript, and not Pik3c2a
or 2g, is abundantly detected in skeletal muscle. Experimen-
tation addressing the role of PIK3C2B in muscle, and its
interplay with the functions of PIK3C3, will obviously be
important to best understand the role of PI(3)P and its regu-
lation in skeletal muscle.ajp.amjpathol.org - The American Journal of Pathology
Pik3c3 Knockout and Muscular DystrophyConclusion
Muscle-speciﬁc conditional knockout of PIK3C3 revealed a
novel murine dystrophy with aberrant autophagy and lyso-
somal function. These novel knockout mice provide a useful
animal model for the study of degradation pathways and their
association to the pathogenesis of muscular dystrophy.
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